COVID-19
FDA Approves Novavax Covid-19 Vaccine for Certain Population Groups
The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness. This decision follows a six-week delay, with the agency citing